{
  "docId": "019de071-753f-7227-aa1d-36a319c59353",
  "docSlug": "7013d0966bfedd0d757b9fa24a480455",
  "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 34,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 24,
  "notes": "Includes footnotes regarding patient exclusions and definitions of LVEF events.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/16",
  "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353",
  "deckJsonHref": "/decks/019de071-753f-7227-aa1d-36a319c59353.json",
  "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.8,
        "x": 0.05,
        "y": 0.43
      },
      "kind": "list",
      "text": "There were no grade 4 or 5 adjudicated drug-related ILD/pneumonitis events observed with T-DXd",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5778ddee-35c8-4a3f-bfe6-f1dd03f1789c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.8,
        "x": 0.05,
        "y": 0.79
      },
      "kind": "list",
      "text": "In the T-DXd arm, all LVEF adverse events reported were asymptomatic and no cases of cardiac failure occurred",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8eb7b70b-e07f-4a8c-94fb-059e80d0c7f0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.033,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "ILD, interstitial lung disease; LVEF, left-ventricular ejection fraction. 1. Patients with prior history of ILD/pneumonitis requiring steroids were excluded 2. Left ventricular dysfunction 3. Decreased ejection fraction.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d0f96bc-6459-48c7-8438-cb28621b6999",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.93,
        "x": 0.033,
        "y": 0.205
      },
      "kind": "table",
      "text": "Adjudicated as drug-related ILD/pneumonitis, n (%)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e640413-2cc3-41b9-96ce-fd1988d49408",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.93,
        "x": 0.033,
        "y": 0.56
      },
      "kind": "table",
      "text": "LVEF, n (%)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0c845e3-22e8-4a63-98c4-7c5dd9bacc23",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.55,
        "x": 0.033,
        "y": 0.065
      },
      "kind": "title",
      "text": "Adverse events of special interest",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6aae936d-cfe4-4961-ae99-18a3d21f00b7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "29c6fcb0-af60-4e56-9e52-aee231e7415f",
      "evidence": "table/data: Adjudicated as drug-related ILD/pneumonitis, n (%)",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 17,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "f6f774ca-af54-4b25-aa3a-3b940b789d31",
      "evidence": "The deck highlights the limitations of current treatments and Enhertu's potential to improve patient outcomes.",
      "position": 0,
      "objective": "What are the consequences of not adopting Enhertu as the standard of care?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}